Ng Wing Nok Isaac, Kalimuthu Shanthini, Law Carmen Oi Kwan, Lee Angeline Hui Cheng, Lau Terrence Chi Kong, Leung Yiu Yan, Cheung Gary Shun Pan, Neelakantan Prasanna
Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, Hong Kong.
Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, Hong Kong.
Int Endod J. 2023 Nov;56(11):1360-1372. doi: 10.1111/iej.13965. Epub 2023 Aug 24.
To determine the effect of a novel antimicrobial peptide (AMP; OP145) and cell-penetrating peptide (Octa-arginine/R8) conjugate on the killing of intracellular Enterococcus faecalis, compared to OP145 and an antibiotic combination recommended for regenerative endodontic procedures.
The biocompatible concentrations of OP145 and OP145-R8 were determined by assessing their cytotoxicity against human macrophages and red blood cells. Spatiotemporal internalization of the peptides into macrophages was investigated qualitatively and quantitatively by confocal laser scanning microscopy and flow cytometry respectively. Killing of extracellular and intracellular E. faecalis OG1RF by the peptides was determined by counting the colony-forming units (CFU). Intracellular antibacterial activity of the peptides was compared to a double antibiotic combination. Confocal microscopy was used to confirm the intracellular bacterial eradication. Significant differences between the different test groups were analysed using one-way analysis of variance. p < .05 was considered to be statistically significant.
Peptides at a concentration of 7.5 μmol/L were chosen for subsequent experiments based on the results of the alamarBlue™ cell viability assay and haemolytic assay. OP145-R8 selectively internalized into lysosomal compartments and the cytosol of macrophages. Conjugation with R8 improved the internalization of OP145 into macrophages in a temporal manner (70.53% at 1 h to 77.13% at 2 h), while no temporal increase was observed for OP145 alone (60.53% at 1 h with no increase at 2 h). OP145-R8 demonstrated significantly greater extracellular and intracellular antibacterial activity compared to OP145 at all investigated time-points and concentrations (p < .05). OP145-R8 at 7.5 μmol/L eradicated intracellular E. faecalis after 2 h (3.5 log reduction compared to the control; p < .05), while the antibiotics could not reduce more than 0.5 log CFU compared to the control (p > .05). Confocal microscopy showed complete absence of E. faecalis within the OP145-R8 treated macrophages.
The results of this study demonstrated that the conjugation of an AMP OP145 to a cell-penetrating peptide R8 eradicated extracellular and intracellular E. faecalis OG1RF without toxic effects on the host cells.
与OP145以及一种推荐用于再生性牙髓治疗程序的抗生素组合相比,确定一种新型抗菌肽(AMP;OP145)与细胞穿透肽(八聚精氨酸/R8)的缀合物对杀灭细胞内粪肠球菌的效果。
通过评估OP145和OP145-R8对人巨噬细胞和红细胞的细胞毒性来确定其生物相容性浓度。分别通过共聚焦激光扫描显微镜和流式细胞术对肽在巨噬细胞中的时空内化进行定性和定量研究。通过计数菌落形成单位(CFU)来确定肽对细胞外和细胞内粪肠球菌OG1RF的杀灭情况。将肽的细胞内抗菌活性与一种双重抗生素组合进行比较。使用共聚焦显微镜确认细胞内细菌的根除情况。使用单因素方差分析来分析不同测试组之间的显著差异。p < 0.05被认为具有统计学意义。
根据alamarBlue™细胞活力测定和溶血测定的结果,选择7.5 μmol/L浓度的肽用于后续实验。OP145-R8选择性内化到巨噬细胞的溶酶体区室和细胞质中。与R8缀合以时间依赖性方式改善了OP145在巨噬细胞中的内化(1小时时为70.53%,2小时时为77.13%),而单独的OP145未观察到时间依赖性增加(1小时时为60.53%,2小时时无增加)。在所有研究的时间点和浓度下,OP145-R8均显示出比OP145显著更高的细胞外和细胞内抗菌活性(p < 0.05)。7.5 μmol/L的OP145-R8在2小时后根除了细胞内粪肠球菌(与对照组相比减少3.5个对数;p < 0.05),而抗生素与对照组相比减少不超过0.5个对数CFU(p > 0.05)。共聚焦显微镜显示在OP145-R8处理的巨噬细胞内完全没有粪肠球菌。
本研究结果表明,抗菌肽OP145与细胞穿透肽R8的缀合物可根除细胞外和细胞内的粪肠球菌OG1RF,且对宿主细胞无毒性作用。